Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04506528 · ClinicalTrials.gov registry record
COVID EHR COHORT at the University of Wisconsin
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 1,634,381
- Enrollment target
NCT04506528: Completed study, sponsored by University of Wisconsin, Madison.
NCT04506528 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,634,381 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04506528 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 1,634,381 participants
- Enrollment target
Study Summary
This cohort study will obtain electronic health record (EHR) data (limited data set) from 21 health systems affiliated with the Cancer Center Cessation Initiative (C3I) network or health systems with large numbers of COVID-19 patients to explore whether smoking status, cancer history, and other risk factors among patients diagnosed with COVID-19 are associated with mortality and/or COVID-19 disease severity/complications. Each site will provide data from their health system EHR on a regular basis that includes all patients identified as having COVID-19 at some point in the interval from February 1, 2020, through January 31, 2022.
Primary Outcome
In analyses of hospitalized patients, all-cause mortality in patients with COVID-19 illness vs discharge from hospital (binary outcome)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,634,381 participants |
| Start Date | 2020-06-11 |
| Est. Completion | 2022-01-31 |
What the finished NCT04506528 record still lists
NCT04506528 is an observational study that tracks outcomes without assigning an intervention. Its 1,634,381 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04506528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04506528 about?
NCT04506528 is a clinical study titled "COVID EHR COHORT at the University of Wisconsin". This cohort study will obtain electronic health record (EHR) data (limited data set) from 21 health systems affiliated with the Cancer Center Cessation Initiative (C3I) network or health systems with large numbers of COVID-19 patients to explore whether smoking status, cancer history, and other risk...
What is the current status of trial NCT04506528?
This trial is currently completed. The enrollment target is 1,634,381 participants. The study started on 2020-06-11. Estimated completion is 2022-01-31.
Who is sponsoring clinical trial NCT04506528?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03813862 · 2,000,000 participants
Observational Pharmaco-Epidemiology Research & Analysis
- NCT06057181 · 2,000,000 participants
Helix Research Network
- NCT07022951 · 1,200,000 participants
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
- NCT05066763 · 1,000,000 participants
Parkinson's Foundation Surveys
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI